Cheryl Reicin is the practice leader of Torys’ Life Science Group, a cross-border group in both Canada and New York. Her group is the only legal group in Canada that is fully dedicated to life science in the financing and corporate area and is consistently ranked as the no 1 life science group in Canada.

 

Cheryl represents the whole spectrum of biotech, medical device and health technology companies, from start-ups to large public companies, as well as venture capitalists, investment banks and academic medical centers. She advises companies, in joint ventures and licensing transactions, private and public financings and mergers and acquisitions throughout the world.

 

Cheryl has the sole distinction of being ranked in international and national rankings as a leading lawyer in life sciences in both the US and Canada and has received numerous recognitions and awards, including, among others, LMG Life Science’s Finance& Transactional Lawyer of the Year; Best Lawyers in Canada – Life Science Lawyer of the Year and Best of the Best – Leading Lawyer in Life Science, Canada’s Top 25 Women of Influence and the Hall of Fame of  Canada's 100 Most Powerful Women.

 

Cheryl is a graduate of Harvard Law School and led a 85 lawyer life science group in the US prior to joining Torys.